XML 31 R17.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED FINANCIAL STATEMENT DETAILS
3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
CONSOLIDATED FINANCIAL STATEMENT DETAILS CONSOLIDATED FINANCIAL STATEMENT DETAILS
Cash and Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheet to the total amounts shown in the consolidated statement of cash flows:
 
March 31, 2020
 
December 31, 2019
 
March 31, 2019
 
December 31, 2018
 
(In thousands)
Cash and cash equivalents
$
2,822,729

 
$
3,139,295

 
$
2,217,337

 
$
2,131,632

Restricted cash included in other current assets
867

 
654

 
1,635

 
1,633

Restricted cash included in other assets
398

 
409

 
416

 
420

Total cash and cash equivalents and restricted cash as shown on the consolidated statement of cash flows
$
2,823,994

 
$
3,140,358

 
$
2,219,388

 
$
2,133,685


Restricted cash at March 31, 2020 and December 31, 2019 primarily consists of a deposit related to corporate credit cards.
Restricted cash at March 31, 2019 and December 31, 2018 primarily consists of a cash collateralized letter of credit and a deposit related to corporate credit cards.
Accumulated Amortization and Depreciation
The following table provides the accumulated amortization and depreciation within the consolidated balance sheet:
Asset Category
March 31, 2020
 
December 31, 2019
 
(In thousands)
Right-of-use assets (included in "other non-current assets")
$
59,237

 
$
47,815

Property, capitalized software and equipment
$
335,766

 
$
324,359

Intangible assets
$
237,567

 
$
215,198


Other (expense) income, net
 
Three Months Ended March 31,
 
2020
 
2019
 
(In thousands)
Other (expense) income, net
$
(49,893
)
 
$
651


Other expense, net in 2020 includes: $51.5 million in impairments (downward adjustments) related to investments in equity securities without readily determinable fair values and $7.5 million in impairments of a note receivable and a warrant related to certain investees due to the impact of COVID-19; and $10.1 million of interest income.
Other income, net in 2019 includes: $12.4 million of interest income; $8.1 million loss related to the sale of a business; and $1.9 million in net foreign currency exchange losses due primarily to the weakening of the U.S. dollar and the Euro relative to the British Pound during the three months ended March 31, 2019.